Princeton University

School of Engineering & Applied Science

Electro-Fluidic Micro- and Nanotechnologies for Health and Environmental Monitoring

Mehdi Javanmard, Rutgers University
Engineering Quadrangle B205
Thursday, November 9, 2017 - 4:30pm

Abstract:  In this talk, I will discuss my groups work on fabricating micro- and nanosensing platforms for biomolecular and biochemical detection. In the first part of my talk, I will discuss a digital microfluidic platform for detection of inflammatory proteins in blood and saliva. I will then discuss a novel scheme for barcoding microparticles nanoelectronically, for multiplexed detection of analytes. We have also developed a novel electrochemical sensor using reduced graphene oxide for detection of inflammatory markers in exhaled breath condenstate for management of chronic respiratory diseases. Finally, I will talk about my groups efforts in developing novel probes for characterization of biological organisms on-the-field in environmental samples, along with sensors for detection of toxic compounds in our regional water sources.
Bio:  Mehdi Javanmard joined Electrical and Computer Engineering Department at Rutgers University in Fall 2014 as Assistant Professor. Before that he was Senior Research Engineer at the Stanford Genome Technology Center (SGTC) in the School of Medicine at Stanford University. He received his BS (2002) from Georgia Institute of Technology and the MS in Electrical Engineering at Stanford University (2004) working at Stanford Linear Accelerator Center researching the use of photonic nanostructures for high energy physics. In 2008, he received his PhD in Electrical Engineering at Stanford University working on development of electronic microfluidic platforms for low cost genomic and proteomic biomarker detection. At SGTC, he worked as a postdoctoral scholar from 2008-2009, and then as a staff engineering research associate from 2009 till 2014. In 2017 he was recipient of the Translational Medicine and Therapeutics Award by the American Society for Clinical Pharmacology & Therapeutics for his group's work in point of care diagnostic tools for assessing patient response to cancer therapies. He has received various awards as Principal Investigator from the National Science Foundation, DARPA, and the PhRMA foundation to support his research. His interests lie in developing portable and wearable technologies for continuous health monitoring and understanding the effects of environment on health.